RecruitingPhase 4NCT07508124

Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants: a Pilot Study

Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants With a First Febrile Urinary Tract Infection: a Multi-center Pilot Study


Sponsor

Baylor College of Medicine

Enrollment

40 participants

Start Date

Apr 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this smaller clinical trial is to evaluate the study design of this research to help prepare for a larger research study in the future. The future larger study would focus on whether steroid cream can reduce recurrent urinary tract infections in male infants, who are not circumcised. Male infants, who are enrolled in this study, would receive either the steroid cream or a placebo cream (a look alike cream without steroids). The cream would be applied twice a week for four weeks. Then there would be two follow up visits with the research team to measure whether the infant experienced any urinary tract infections and to measure parent perceptions of their experience participating in the study.


Eligibility

Sex: MALEMin Age: 0 MonthsMax Age: 5 Months

Inclusion Criteria3

  • Uncircumcised male infants \< 6 months old
  • Both physician and laboratory confirmed diagnosis of first UTI
  • Fever (temperature ≥38.0 C) or hypothermia (temperature \<36.0 C) per ED/hospitalization or parental report

Exclusion Criteria10

  • Legal guardian not available to provide informed consent
  • Infant in Child Protective Services (CPS) custody
  • Legal guardian would like Urology referral for circumcision
  • Circumcision is medically indicated due to recurrent episodes of balanitis or ballooning of foreskin during urination
  • Past diagnosis of penile abnormalities (diagnoses of epispadius, hypospadias or congenital penile curvature (chordee))
  • Prior use of topical steroid therapy for phimosis
  • History of hypersensitivity to topical steroids
  • Legal guardian is not fluent in English OR Spanish
  • Foreskin assessed to be fully retractable
  • Open wounds present on penis or in groin region

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGbetamethasone valerate 0.1% cream

Steroid cream applied to the foreskin and glans twice a day for four weeks.

DRUGPlacebo cream

Placebo cream is applied to the foreskin and glans twice a day for four weeks.


Locations(3)

Texas Children's Hospital Main campus

Houston, Texas, United States

Texas Children's Hospital West Campus

Katy, Texas, United States

Seattle Children's Hospital

Seattle, Washington, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07508124


Related Trials